Literature DB >> 28912188

Modern Imaging Techniques in Cardiomyopathies.

M Fuad Jan1, A Jamil Tajik2.   

Abstract

Modern advanced imaging techniques have allowed increasingly more rigorous assessment of the cardiac structure and function of several types of cardiomyopathies. In contemporary cardiology practice, echocardiography and cardiac magnetic resonance imaging are widely used to provide a basic framework in the evaluation and management of cardiomyopathies. Echocardiography is the quintessential imaging technique owing to its unique ability to provide real-time images of the beating heart with good temporal resolution, combined with its noninvasive nature, cost-effectiveness, availability, and portability. Cardiac magnetic resonance imaging provides data that are both complementary and uniquely distinct, thus allowing for insights into the disease process that until recently were not possible. The new catchphrase in the evaluation of cardiomyopathies is multimodality imaging, which is purported to be the efficient integration of various methods of cardiovascular imaging to improve the ability to diagnose, guide therapy, or predict outcomes. It usually involves an integrated approach to the use of echocardiography and cardiac magnetic resonance imaging for the assessment of cardiomyopathies, and, on occasion, single-photon emission computed tomography and such specialized techniques as pyrophosphate scanning.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  cardiomyopathies; echocardiography; magnetic resonance imaging

Mesh:

Year:  2017        PMID: 28912188     DOI: 10.1161/CIRCRESAHA.117.309600

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  10 in total

Review 1.  Advances in MRI Applications to Diagnose and Manage Cardiomyopathies.

Authors:  Ramya Vajapey; Brendan Eck; Wilson Tang; Deborah H Kwon
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-27

Review 2.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Authors:  Ali J Marian; Eugene Braunwald
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

Review 3.  Hypertrophic cardiomyopathy: genetics and clinical perspectives.

Authors:  Cordula Maria Wolf
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

4.  Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry.

Authors:  Katarzyna Mizia-Stec; Philippe Charron; Juan Ramon Gimeno Blanes; Perry Elliott; Juan Pablo Kaski; Aldo P Maggioni; Luigi Tavazzi; Michał Tendera; Stephan B Felix; Fernando Dominguez; Natalia Ojrzynska; Maria-Angela Losi; Giuseppe Limongelli; Roberto Barriales-Villa; Petar M Seferovic; Elena Biagini; Maciej Wybraniec; Cecile Laroche; Alida L P Caforio
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2021-06-22       Impact factor: 6.875

Review 5.  Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Adverse Drug-Induced Inotropic Effects in Early Drug Development. Part 1: General Considerations for Development of Novel Testing Platforms.

Authors:  Brian D Guth; Michael Engwall; Sandy Eldridge; C Michael Foley; Liang Guo; Gary Gintant; John Koerner; Stanley T Parish; Jennifer B Pierson; Alexandre J S Ribeiro; Tanja Zabka; Khuram W Chaudhary; Yasunari Kanda; Brian Berridge
Journal:  Front Pharmacol       Date:  2019-08-09       Impact factor: 5.810

Review 6.  Dilated cardiomyopathies and non-compaction cardiomyopathy.

Authors:  A Hänselmann; C Veltmann; J Bauersachs; D Berliner
Journal:  Herz       Date:  2020-05       Impact factor: 1.443

Review 7.  Cardiovascular magnetic resonance: contribution to the exploration of cardiomyopathies.

Authors:  Călin Schiau; Şerban Schiau; Sorin M Dudea; Simona Manole
Journal:  Med Pharm Rep       Date:  2019-10-25

Review 8.  Dilated cardiomyopathy.

Authors:  Heinz-Peter Schultheiss; DeLisa Fairweather; Alida L P Caforio; Felicitas Escher; Ray E Hershberger; Steven E Lipshultz; Peter P Liu; Akira Matsumori; Andrea Mazzanti; John McMurray; Silvia G Priori
Journal:  Nat Rev Dis Primers       Date:  2019-05-09       Impact factor: 65.038

9.  A New SCN5A Variant in a Patient with Idiopathic Ventricular Fibrillation: The Dark Side of Cardiac Imaging.

Authors:  Rossella Maria Benvenga; Maria Vincenza Polito; Costantina Prota; Santo Dellegrottaglie; Nicola Ragosa; Gianpaolo D'Arco; Valentino Ducceschi; Antonio Aloia
Journal:  J Cardiovasc Echogr       Date:  2022-01-24

Review 10.  Cardiac magnetic resonance in the assessment of hypertrophic cardiomyopathy phenotypes and stages - pictorial review.

Authors:  Magdalena Stachera; Paweł Przybyło; Katarzyna Sznajder; Marek Gierlotka
Journal:  Pol J Radiol       Date:  2021-12-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.